Literature DB >> 18000980

Developmental signaling pathways in brain tumor-derived stem-like cells.

Paul A Clark1, Daniel M Treisman, Johnathan Ebben, John S Kuo.   

Abstract

Recently, a subpopulation of cells highly efficient in tumor initiation and growth has been isolated from brain tumors. Of interest, these brain tumor initiating cells exhibit many stem-like properties, including self-renewal, extended proliferation, and multipotency, and are both phenotypically and genetically similar to normal neural stem cells (NSCs). Aberrant expression of developmental pathways, such as WNT, Hedgehog, Notch, and transforming growth factor-beta/bone morphogenetic protein, have been demonstrated in brain tumors, and extrinsic regulation of these pathways may be used to target brain tumor stem-like cells (BTSCs) and form the basis of novel biological therapies. Because of regulatory redundancy during normal development, future therapeutic strategies to inhibit BTSC-mediated tumor growth and minimize NSC-related deleterious effects may require detailed understanding and regulation of multiple cellular mechanisms. This review analyzes the role developmental pathways play in brain tumors, focusing on the potential effects of pathway regulation on BTSC-driven tumorigenesis. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000980     DOI: 10.1002/dvdy.21381

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  28 in total

1.  Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.

Authors:  Michael Zorniak; Paul A Clark; John S Kuo
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

2.  Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells.

Authors:  Jehad Algharabil; Douglas B Kintner; Qiwei Wang; Gulnaz Begum; Paul A Clark; Sung-Sen Yang; Shih-Hua Lin; Kristopher T Kahle; John S Kuo; Dandan Sun
Journal:  Cell Physiol Biochem       Date:  2012-06-08

Review 3.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

4.  Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration.

Authors:  Yu Huang; Basheal Agrawal; Dandan Sun; John S Kuo; Justin C Williams
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

5.  Upregulation of E2F1 in cerebellar neuroprogenitor cells and cell cycle arrest during postnatal brain development.

Authors:  Daniela E Suzuki; Carolina B Ariza; Marimélia A Porcionatto; Oswaldo Keith Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

6.  Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.

Authors:  Xing-Gang Mao; Xiang Zhang; Xiao-Yan Xue; Geng Guo; Peng Wang; Wei Zhang; Zhou Fei; Hai-Ning Zhen; Si-Wei You; Hao Yang
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.

Authors:  Pablo Menendez; Purificación Catalina; René Rodríguez; Gustavo J Melen; Clara Bueno; Mar Arriero; Félix García-Sánchez; Alvaro Lassaletta; Ramón García-Sanz; Javier García-Castro
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

Review 8.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

Review 9.  Progress on potential strategies to target brain tumor stem cells.

Authors:  Xing-gang Mao; Xiang Zhang; Hai-ning Zhen
Journal:  Cell Mol Neurobiol       Date:  2008-09-10       Impact factor: 5.046

Review 10.  The transcription factor ATF5: role in neurodevelopment and neural tumors.

Authors:  Lloyd A Greene; Hae Young Lee; James M Angelastro
Journal:  J Neurochem       Date:  2008-11-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.